Today Allcure Healthcare has strong ground presence in all these markets where the brand promotion is done by our own sales team. We have more than 150 brands in these markets and large number of them hold sizeable market share and enjoy leadership positions.
Allcure Healthcare has acquired strong capabilities of identifying gaps in its market place, obtaining the regulatory approvals for new products and then launching them successfully to make them into sizeable brand. Our sales and marketing capabilities are 2nd to none having laser focused determination on execution.
In Emerging Markets, we have presence in wide range of therapeutic segments like, Cardiology, Anti-Diabetes, Ophthalmology, Antibiotic, Anti-Malarial, Pain, Respiratory, Gynaecology, Paediatric and General Health products.
Our strategy is to have a selective play in this market with launching limited competition products. All the products are marketed through our subsidiary Allcure Healthcare African Inc.
We were the 1st generic player pre-qualified by WHO Geneva for this product and hold leadership position in the segment. With focus on Africa’s hardest malaria hit countries we have been able to treat over 1 billion patients in about a decade. We are committed to bringing more of our medicines to more people, no matter where they are.
We have robust product pipeline under regulatory approvals in these markets which will further consolidate our leadership positions in sub-therapeutic and therapeutic segments.
We continue to work with all major distributors in the market with an impeccable service record which has strengthened our position as a partner of first-choice.
